Management of Acute Pancreatitis Associated With Checkpoint Inhibitors

Pancreatitis is a rare immune-related adverse event (irAE) associated with the use of immune checkpoint inhibitors (ICIs). It is more often associated with combined immunotherapy than by any single agent. Early signs of pancreatitis may only include elevation of lipase and amylase. Additional sympto...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogers, Barbara Barnes, Cuddahy, Terri, Zawislak, Carolyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2020
Materias:
Grand Rounds
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517772/
https://www.ncbi.nlm.nih.gov/pubmed/33542849
http://dx.doi.org/10.6004/jadpro.2020.11.1.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517772/
https://www.ncbi.nlm.nih.gov/pubmed/33542849
http://dx.doi.org/10.6004/jadpro.2020.11.1.3

Ejemplares similares